{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T10:46:27Z","timestamp":1772448387395,"version":"3.50.1"},"reference-count":64,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"vor","delay-in-days":1461,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1038\/ki.2011.473","type":"journal-article","created":{"date-parts":[[2012,2,9]],"date-time":"2012-02-09T11:12:15Z","timestamp":1328785935000},"page":"903-918","source":"Crossref","is-referenced-by-count":39,"title":["Erythropoietin, but not the correction of anemia alone, protects from chronic kidney allograft injury"],"prefix":"10.1016","volume":"81","author":[{"given":"Paola","family":"Cassis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Gallon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariela","family":"Benigni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilena","family":"Mister","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Pezzotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha","family":"Solini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Gagliardini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Cugini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Abbate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sistiana","family":"Aiello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Rocchetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierangela","family":"Scudeletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norberto","family":"Perico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Noris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Remuzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/ki.2011.473_bb0010","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1600-6143.2006.01688.x","article-title":"Banff \u201805 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy (\u2018CAN\u2019)","volume":"7","author":"Solez","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1038\/ki.2011.473_bb0015","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1111\/j.1600-6143.2004.00662.x","article-title":"Assessing long-term nephron loss: is it time to kick the CAN grading system?","volume":"4","author":"Halloran","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1038\/ki.2011.473_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1523-1755.2005.00376.x","article-title":"Chronic renal allograft rejection: pathophysiologic considerations","volume":"68","author":"Joosten","year":"2005","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2011.473_bb0025","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1097\/01.tp.0000205174.97275.b5","article-title":"Posttransplantation anemia in adult renal allograft recipients: prevalence and predictors","volume":"81","author":"Shah","year":"2006","journal-title":"Transplantation"},{"key":"10.1038\/ki.2011.473_bb0030","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/j.1600-6143.2006.01727.x","article-title":"Anemia is associated with mortality in kidney-transplanted patients\u2014a prospective cohort study","volume":"7","author":"Molnar","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1038\/ki.2011.473_bb0035","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.2215\/CJN.04641007","article-title":"Impact of anemia after renal transplantation on patient and graft survival and on rate of acute rejection","volume":"3","author":"Chhabra","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2011.473_bb0040","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1681\/ASN.2005070757","article-title":"Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure","volume":"17","author":"Nangaku","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2011.473_bb0045","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1159\/000020625","article-title":"Hypoxia-induced changes in extracellular matrix metabolism in renal cells","volume":"7","author":"Norman","year":"1999","journal-title":"Exp Nephrol"},{"key":"10.1038\/ki.2011.473_bb0050","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000084275","article-title":"Attenuation of interstitial inflammation and fibrosis by recombinant human erythropoietin in chronic cyclosporine nephropathy","volume":"25","author":"Lee","year":"2005","journal-title":"Am J Nephrol"},{"key":"10.1038\/ki.2011.473_bb0055","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1161\/01.CIR.0000139335.04152.F3","article-title":"Low-dose therapy with the long-acting erythropoietin analogue darbepoetin alpha persistently activates endothelial Akt and attenuates progressive organ failure","volume":"110","author":"Bahlmann","year":"2004","journal-title":"Circulation"},{"key":"10.1038\/ki.2011.473_bb0060","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1007\/s00467-008-0903-1","article-title":"Protective effect of EPO on oxidative renal injury in rats with cyclosporine nephrotoxycity","volume":"23","author":"Kasap","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"10.1038\/ki.2011.473_bb0065","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0272-6386(12)80671-8","article-title":"Effects of recombinant human erythropoietin on renal function in chronic renal failure predialysis patients","volume":"24","author":"Roth","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2011.473_bb0070","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1523-1755.2004.00797.x","article-title":"Treating anemia early in renal failure patients slows the decline of renal function: a randomized controlled trial","volume":"66","author":"Gouva","year":"2004","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2011.473_bb0075","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2369-4-3","article-title":"R.hu-erythropoietin (EPO) treatment of pre-ESRD patients slows the rate of progression of renal decline","volume":"4","author":"Tapolyai","year":"2003","journal-title":"BMC Nephrol"},{"key":"10.1038\/ki.2011.473_bb0080","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa062276","article-title":"Normalization of hemoglobin level in patients with chronic kidney disease and anemia","volume":"355","author":"Dru\u00ebke","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2011.473_bb0085","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1093\/ndt\/17.9.1667","article-title":"Erythropoietin therapy may retard progression in chronic renal transplant dysfunction","volume":"17","author":"Becker","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2011.473_bb0090","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/S0041-1345(03)00732-2","article-title":"Use of recombinant human erythropoietin in kidney transplant patients with stable graft function","volume":"35","author":"Ortiz","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1038\/ki.2011.473_bb0095","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s004670050392","article-title":"Subcutaneous recombinant human erythropoietin in chronic renal allograft dysfunction","volume":"12","author":"Aufricht","year":"1998","journal-title":"Pediatr Nephrol"},{"key":"10.1038\/ki.2011.473_bb0100","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1365-2141.2008.07014.x","article-title":"The non-haematopoietic biological effects of erythropoietin","volume":"141","author":"Arcasoy","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1038\/ki.2011.473_bb0105","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/sj.ki.5002311","article-title":"Podocyte protection by darbepoetin: preservation of the cytoskeleton and nephrin expression","volume":"72","author":"Eto","year":"2007","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2011.473_bb0110","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/sj.ki.5002362","article-title":"Darbepoetin alfa protects podocytes from apoptosis in vitro and in vivo","volume":"72","author":"Logar","year":"2007","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2011.473_bb0115","doi-asserted-by":"crossref","first-page":"6142","DOI":"10.1073\/pnas.85.16.6142","article-title":"Anemia lessens and its prevention with recombinant human erytropoietin worsens glomerular injury and hypertension in rats with reduced renal mass","volume":"85","author":"Garcia","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/ki.2011.473_bb0120","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.amjhyper.2006.06.019","article-title":"Anti hypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin","volume":"19","author":"Lebel","year":"2006","journal-title":"Am J Hypertens"},{"key":"10.1038\/ki.2011.473_bb0125","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1159\/000189052","article-title":"Long-term erythropoietin in rats with reduced renal mass","volume":"73","author":"Torralbo","year":"1996","journal-title":"Nephron"},{"key":"10.1038\/ki.2011.473_bb0130","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1681\/ASN.2006010090","article-title":"Adeno-associated virus-mediated CTLA4Ig gene transfer protects MHC-mismatched renal allografts from chronic rejection","volume":"17","author":"Benigni","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2011.473_bb0135","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/ki.1995.30","article-title":"Toward novel antirejection strategies: in vivo immunosuppressive properties of CTLA4-Ig","volume":"47","author":"Perico","year":"1995","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2011.473_bb0140","doi-asserted-by":"crossref","first-page":"G813","DOI":"10.1152\/ajpgi.00306.2005","article-title":"Adrenergic receptor agonists prevent bile duct injury induced by adrenergic denervation by increased cAMP levels and activation of Akt","volume":"290","author":"Glaser","year":"2005","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1038\/ki.2011.473_bb0145","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.trre.2010.01.006","article-title":"Posttransplant anemia in solid organ recipient","volume":"24","author":"Blosser","year":"2010","journal-title":"Transplant Rev"},{"key":"10.1038\/ki.2011.473_bb0150","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1681\/ASN.V1291937","article-title":"Combined treatment with mycophenolate mofetil and an angiotensin II receptor antagonist fully protects from chronic rejection in a rat model of renal allograft","volume":"12","author":"Noris","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2011.473_bb0155","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1034\/j.1600-6143.2002.20509.x","article-title":"Expression of inducible and endothelial nitric oxide synthases, formation of peroxynitrite and reactive oxygen species in human chronic renal transplant failure","volume":"2","author":"Albrecht","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1038\/ki.2011.473_bb0160","doi-asserted-by":"crossref","first-page":"11853","DOI":"10.1073\/pnas.93.21.11853","article-title":"Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts","volume":"93","author":"MacMillan-Crow","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/ki.2011.473_bb0165","doi-asserted-by":"crossref","first-page":"F324","DOI":"10.1152\/ajprenal.00026.2005","article-title":"Low-dose carbon monoxide inhalation prevents development of chronic allograft nephropathy","volume":"290","author":"Neto","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1038\/ki.2011.473_bb0170","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1161\/01.RES.0000224117.59417.f3","article-title":"Erythropoietin-mobilized endothelial progenitors enhance reendothelialization via Akt-endothelial nitric oxide synthase activation and prevent neointimal hyperplasia","volume":"98","author":"Urao","year":"2006","journal-title":"Circ Res"},{"key":"10.1038\/ki.2011.473_bb0175","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1681\/ASN.V1271434","article-title":"Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1","volume":"12","author":"Kang","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2011.473_bb0180","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1034\/j.1399-0012.2000.0140s3006.x","article-title":"Rejection of peritubular capillaries in renal allo- and xeno-graft","volume":"14","author":"Shimizu","year":"2000","journal-title":"Clin Transplant"},{"key":"10.1038\/ki.2011.473_bb0185","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/00007890-199209000-00020","article-title":"Induction of specific tolerance to class I-disparate renal allografts in miniature swine with cyclosporine","volume":"54","author":"Rosengard","year":"1992","journal-title":"Transplantation"},{"key":"10.1038\/ki.2011.473_bb0190","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0006-291X(03)01557-2","article-title":"Hypoxia induces apoptosis in SV40-immortalized rat proximal tubular cells through the mitochondrial pathways, devoid of HIF1-mediated upregulation of Bax","volume":"309","author":"Tanaka","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1038\/ki.2011.473_bb0195","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1046\/j.1523-1755.1999.055003808.x","article-title":"Human, rat, and mouse kidney cells express functional erythropoietin receptors","volume":"55","author":"Westenfelder","year":"1999","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2011.473_bb0200","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/ki.1995.113","article-title":"Recombinant human erythropoietin stimulates angiogenesis in vitro","volume":"47","author":"Carlini","year":"1995","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2011.473_bb0205","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0014-2999(99)00281-2","article-title":"Recombinant human erythropoietin stimulates vascular endothelial growth factor release by glomerular endothelial cells","volume":"373","author":"Nitta","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1038\/ki.2011.473_bb0210","doi-asserted-by":"crossref","first-page":"F1504","DOI":"10.1152\/ajprenal.00025.2010","article-title":"Enhanced progenitor cell recruitment and andothelial repair after selective endothelial injury of mouse kidney","volume":"298","author":"Hohenstein","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1038\/ki.2011.473_bb0215","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1097\/01.tp.0000264200.38926.70","article-title":"Erythropoietin protects the kidneys against ischemia reperfusion injury by activating hypoxia inducible factor-1alpha","volume":"83","author":"Imamura","year":"2007","journal-title":"Transplantation"},{"key":"10.1038\/ki.2011.473_bb0220","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1681\/ASN.V132544","article-title":"Human podocytes express angiopoietin 1, a potential regulator of glomerular vascular endothelial growth factor","volume":"13","author":"Satchell","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2011.473_bb0225","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/10623320600697989","article-title":"Angiopoietins and angiopoietin-like proteins in angiogenesis","volume":"13","author":"Morisada","year":"2006","journal-title":"Endothelium"},{"key":"10.1038\/ki.2011.473_bb0230","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/ki.1994.386","article-title":"Expression and distribution of epidermal growth factor in acute and chronic renal allograft rejection","volume":"46","author":"Stein-Oakley","year":"1994","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2011.473_bb0235","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/01.tp.0000195773.24217.95","article-title":"Differential expression of profibrotic and growth factors in chronic allograft nephropathy","volume":"81","author":"Hotchkiss","year":"2006","journal-title":"Transplantation"},{"key":"10.1038\/ki.2011.473_bb0240","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/ndt\/gfg547","article-title":"Erythropoietin protects against ischaemic acute renal injury","volume":"19","author":"Vesey","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2011.473_bb0245","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1038\/sj.ki.5000356","article-title":"Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure","volume":"69","author":"Johnson","year":"2006","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2011.473_bb0250","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1126\/science.1098313","article-title":"Derivatives of erythropoietin that are tissue protective but not erythropoietic","volume":"305","author":"Leist","year":"2004","journal-title":"Science"},{"key":"10.1038\/ki.2011.473_bb0255","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.imlet.2007.12.008","article-title":"Critical roles of the PI3K\/Akt signaling pathway in T cell development","volume":"116","author":"Juntilla","year":"2008","journal-title":"Immunol Lett"},{"key":"10.1038\/ki.2011.473_bb0260","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1034\/j.1600-065X.2003.00008.x","article-title":"The PI-3 kinase\/Akt pathway and T cell activation: pleiotropic pathways downstream of PIP3","volume":"192","author":"Kane","year":"2003","journal-title":"Immunol Rev"},{"key":"10.1038\/ki.2011.473_bb0265","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.2215\/CJN.03040707","article-title":"Late kidney allograft loss: what we know about it, and what we can do about it","volume":"3","author":"Jevnikar","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2011.473_bb0270","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/MNH.0b013e3282f4e514","article-title":"Chronic allograft nephropathy","volume":"17","author":"Najafian","year":"2008","journal-title":"Current Opinion Nephrol Hypertens"},{"key":"10.1038\/ki.2011.473_bb0275","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0344-0338(11)81021-6","article-title":"The consequences of tubulo-interstitial changes for renal function in glomerulopathies. A morphometric and cytological analysis","volume":"186","author":"Bohle","year":"1990","journal-title":"Pathol Res Pract"},{"key":"10.1038\/ki.2011.473_bb0280","doi-asserted-by":"crossref","first-page":"26734","DOI":"10.1074\/jbc.272.42.26734","article-title":"Hydroxyl radicals depolymerize glomerular heparan sulfate in vitro and in experimental nephrotic syndrome","volume":"272","author":"Raats","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1038\/ki.2011.473_bb0285","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2337\/diabetes.55.01.06.db05-0894","article-title":"Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy","volume":"55","author":"Susztak","year":"2006","journal-title":"Diabetes"},{"key":"10.1038\/ki.2011.473_bb0290","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1159\/000178762","article-title":"The contribution of podocytes to chronic allograft nephropathy","volume":"111","author":"Pippin","year":"2009","journal-title":"Nephron Exp Nephrol"},{"key":"10.1038\/ki.2011.473_bb0295","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1681\/ASN.2004121084","article-title":"Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome","volume":"16","author":"Koshikawa","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2011.473_bb0300","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.febslet.2006.12.051","article-title":"Transcriptional suppression of nephrin in podocytes by macophages. role of inflammatory cytokines and involvement of the PI3K\/Akt pathway","volume":"581","author":"Takano","year":"2007","journal-title":"FEBS Lett"},{"key":"10.1038\/ki.2011.473_bb0305","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000092213","article-title":"A role for heme oxygenase-1 in the antioxidant and antiapoptotic effects of erythropoietin: the start of a good news\/bad news story?","volume":"103","author":"Calo","year":"2006","journal-title":"Nephron Physiol"},{"key":"10.1038\/ki.2011.473_bb0310","doi-asserted-by":"crossref","first-page":"b4018","DOI":"10.1136\/bmj.b4018","article-title":"Mortality in renal transplant recipients given erythropoietins to increase haemoglobin concentration: cohort study","volume":"339","author":"Heinze","year":"2009","journal-title":"Br Med J"},{"key":"10.1038\/ki.2011.473_bb0315","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1056\/NEJMoa071533","article-title":"Efficacy and saf ety of epoetin alfa in critically ill patients","volume":"357","author":"Corwin","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2011.473_bb0320","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2796.2008.02024.x","article-title":"Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response","volume":"264","author":"Brines","year":"2008","journal-title":"J Intern Med"},{"key":"10.1038\/ki.2011.473_bb0325","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/sj.ki.5000006","article-title":"Efficacy and immunogenicity of novel erythropoietic agents and conventional rhEPO in rats with renal insufficiency","volume":"69","author":"Tillmann","year":"2006","journal-title":"Kidney Int"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815554082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815554082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,28]],"date-time":"2021-12-28T09:09:10Z","timestamp":1640682550000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815554082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":64,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0085253815554082"],"URL":"https:\/\/doi.org\/10.1038\/ki.2011.473","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}